Diabetes mellitus is a group of metabolic diseases that is characterised by high blood sugar levels. This occurs either because the body does not produce enough insulin or because cells do not respond to the insulin that is produced. In the past few decades, many studies have shown a clear worldwide increase in the incidence of both type 1 and type 2 diabetes mellitus.
INTRODUCTION
Diabetes mellitus is a group of metabolic diseases that is characterised by high blood sugar levels. This occurs either because the body does not produce enough insulin or because cells do not respond to the insulin that is produced. In the past few decades, many studies have shown a clear worldwide increase in the incidence of both type 1 and type 2 diabetes mellitus.
(1) Without proper treatment, diabetes mellitus can cause many long-term complications, including cardiovascular disease, chronic renal failure, blindness and nerve damage. Microangiopathy, which is caused by vascular endothelial cell injury and dysfunction, is a fundamental process in diabetes mellitus complications. (2) (3) (4) Drug interventions are needed to treat these microvascular complications.
Reactive oxygen species (ROS) play a crucial role in the pathogenesis of some diseases (e.g. cancer, cardiovascular disease, diabetes mellitus and infl ammation). (5) The effect of the increased production of free radicals in diabetes mellitus is devastating and well documented. (6) (7) (8) Streptozotocin (STZ)-induced diabetic rats are one of the animal models for type 1 diabetes mellitus. (9) In type 1 diabetes mellitus, destruction of the β-cells of the islets of Langerhans causes degranulation or reduction of insulin secretion, but not the total absence of insulin in blood. (10) The cytotoxic action of STZ is associated with the generation of ROS, which causes oxidative tissue damage. (11) There is considerable evidence of the role of altered antioxidant defences (including both nonenzymatic and enzymatic antioxidant systems) and free radicals in the aetiology of diabetes mellitus. (12, 13) Many studies have reported that the use of traditional Chinese medicines not only helps to lower serum glucose, but also helps to inhibit the development of diabetic complications. ( 14, 15) Our previous research, which was conducted on umbilical vein endothelial cells (ECV-304), found that Xiaokening effectively reduces cellular injury and proliferation inhibition resulting from high glucose serum levels. (16, 17) In other words, Xiaokening was found to have protective effects for endothelial cells and the ability to improve cell propagation. These fi ndings indicate that Xiaokening has a positive effect on endothelial cells in vitro. However, there is little information on the effect of Xiaokening on endothelial cells within vessels. As the effect of Xiaokening on diabetic arterioles has not been reported, the aim of the present study was to explore its effect on the mesenteric arteriolar endothelial cell function of diabetic rats and the underlying mechanism.
METHODS
STZ and 2,3-diaminonaphthalene (DAN) were purchased from Sigma Chemical Company, MO, USA. The STZ was dissolved in a solution of cold citrate buffer (0.1 M, pH 4.5). The DAN was dissolved in methanol. The STZ and DAN solutions used in the present study were freshly dissolved and shielded from light. Antibody for endothelial nitric oxide synthase (eNOS) was purchased from Santa Cruz Biotechnology, TX, USA. The kits for METHODS Diabetes mellitus was induced in rat models via intraperitoneal injection of 60 mg/kg streptozotocin and observed over three weeks. Mesenteric arterioles, which were isolated in a cannulated and pressurised state, were incubated with intravascular injections of 1, 3 or 5 g/L Xiaokening for 24, 48 or 72 hours. The effects of Xiaokening on the release of nitric oxide (NO) on the mesenteric arterioles were detected under shear stress of 1, 10 and 20 dyn/cm 2 . Biochemical methods were used to determine the activities of superoxide dismutase (SOD) and xanthine oxidase (XO). The expressions of endothelial NO synthase (eNOS), SOD and XO in the mesenteric arterioles were assessed using Western blot.
measuring superoxide anion (O 2 -) content, superoxide dismutase (SOD) activity and xanthine oxidase (XO) activity were from Nanjing Jiancheng Bioengineering Institute, Nanjing, China. Xiaokening (national patent no. 200410064899X) is composed of prepared rhubarb, radix aconiti lateralis preparata and crude radix astragali. It is an alcohol extract prepared via fractionation by column chromatography followed by high performance liquid chromatography-mass spectrometry. The Xiaokening used in the present study was made by the School of Pharmacy, Xuzhou Medical College, China.
Male Sprague-Dawley rats that weighed about 200 g were obtained from the Experimental Animal Center, Xuzhou Medical College, China. All animal procedures were performed with the approval of the Ethics Committee for the Use of Experimental Animals of Xuzhou Medical College, China (SCXK2010-0003). The rats were divided into two groups: the control group (n = 6) and the STZ-induced diabetic group (n = 24). After overnight fasting (i.e. the rats were deprived of food for 12 hours but given free access to water), diabetes mellitus was induced via an intraperitoneal (IP) injection of STZ at a dose of 60 mg/kg. The blood glucose concentrations of these STZ-treated rats were determined on the 7th, 14th and 21st day after the injection. The rats that had blood glucose levels that were greater than 11.1 mmol/L were considered diabetic and detained for the experiments. Rats in the control group received 60 mg/kg IP injection of citrate buffer.
The STZ-induced diabetic rats and control rats were anaesthetised with 10% chloral hydrate (400 mg/kg IP) on the 21st day. Experiments were conducted on arterioles that were isolated from the rat's mesentery. About 10-mm lengths of fi rst-order mesenteric arterioles that had diameters of about 300 μm were obtained and used as detector vessels. Mesenteric arterioles were used because a suffi cient number of vessels can be obtained from the mesentery for biochemical analysis and Western blot.
All perfusion chambers, tubing, reservoirs and connectors were autoclaved prior to use. The perfusion system was placed in a vertical cell culture hood in order to maintain a sterile environment. The perfusion system consists of four 1-mL perfusion chambers that provide an identical experimental environment for four single vessels. The intravascular pressure of the vessels was maintained by four separate pressure reservoirs. The height of the reservoirs was precisely controlled.
In the present study, the isolated first-order mesenteric arterioles of the control and STZ-induced diabetic rats were cultured in perfusion chambers using Dulbecco's Modifi ed Eagle's Medium (DMEM). To observe the effect of Xiaokening on the arterioles of STZ-induced diabetic rats, 1, 3 and 5 g/L of Xiaokening were injected into the arterioles of these rats using a microelectrode and the arterioles were placed in an incubator for 24, 48 or 72 hours. The DMEM and intravascular Xiaokening mixture was changed once every four hours.
Nitrite is an existing form of nitric oxide (NO) in physiological saline solution. It reacts with DAN to form 1-(H) naphthoteiazole, which fl uoresces when its molecules are excited at 375 nm (emission is collected at 415 nm). Similar to that which was done in our previous study, (18) the fi rst-order arteries were incubated with Xiaokening for 24, 48 propanesulphonic acid)-buffered physiological salt solution for NO release measurements. After the internal diameter and length of the vessels were measured under a microscope, wall shear stress of 1, 10 and 20 dyn/cm 2 were established by increasing perfusate fl ow using a syringe pump that was connected to an in-line pressure transducer that monitors infl ow pressure. The outfl ow pressure was adjusted accordingly to maintain constant intravascular pressure. Perfusate (400 μL) at the outfl ow tubing was collected at each level of shear stress. Standard curves of nitrite (0-640 μM) were constructed using MOPS as a vehicle and NO level was expressed as fl uorescence intensity. Nitrite production in response to shear stress was expressed as pmol/mm 2 of the lumen surface of the arterioles per minute.
After perfusion, three or four mesenteric arteries were collected and homogenated. The protein concentration in the supernatant was determined using the bicinchoninic acid assay (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). O 2 -content, and SOD and XO activities were assayed according to the commercial kits' manuals (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). O 2 -content was expressed as unit/g protein, while SOD and XO activities were expressed as unit/ mg protein.
The arteries were pulverised in liquid nitrogen after perfusion and the samples were solubilised in a lysis buffer in ice for 30 minutes, followed by two one-minute sonications with a fi ve-minute interval. The mesenteric arterioles were isolated and pooled to denature the proteins. Samples containing 10 μg of protein were separated on sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) gels (10% acrylamide) and transferred to a polyvinyl difl uoride membrane. The membrane was then probed with primary antibodies for eNOS. Secondary antibodies were conjugated to horseradish peroxidase, according to the NBT/BCIP protocol. β-actin was used to normalise for loading variations.
Data was presented as mean ± standard error. Statistical signifi cance was assessed using one-way analysis of variance (ANOVA), followed by a post hoc (Bonferroni) test for a multiple group comparison. Differences that had a p-value < 0.05 were considered statistically signifi cant.
RESULTS
To investigate the effect Xiaokening has on the endothelial function of arteries in STZ-induced diabetic rats, the mesenteric arterioles of the rats were isolated and incubated with or without Xiaokening for 24, 48 or 72 hours. NO release from the arterioles was then assessed during the induction of different shear stress pressures (1, 10 and 20 dyn/cm 2 ). The NO release in response to shear stress was lower in the arterioles from the STZ-induced diabetic rats as compared to that of the arterioles from the control group (Fig. 1, p < 0.05) . Xiaokening (1, 3 or 5 g/L) was found to have a concentration-and time-dependent effect on NO release in the arterioles. Incubation with 5 g/L Xiaokening for 72 hours had the best effect in reversing shear stress-induced NO release in arterioles from STZ-induced diabetic rats. Therefore, we used 5 g/L Xiaokening and 72-hour incubation to explore the underlying mechanism through which Xiaokening protects arteriole endothelial function in these rats.
Compared to the arterioles of the control group, eNOS expression was signifi cantly lower in the mesenteric arterioles of the STZ-induced diabetic rats (p < 0.05). Incubation with 5 g/L Xiaokening for 72 hours reversed the decrease in eNOS expression in the arterioles of STZ-induced diabetic rats (Fig. 2) .
It is well known that diabetes-induced endothelial cell damage is caused by oxidative stress. In the present study, we found that O 2 -content in the arterioles of STZ-induced diabetic rats was signifi cantly greater than that in the arterioles of the control rats (Fig. 3) . Incubation with 5 g/L Xiaokening for 72 hours signifi cantly decreased the O 2 -content in the arterioles of the diabetic rats. This indicates that Xiaokening reverses diabetesinduced endothelial damage by removing O 2 -. SOD is responsible for destroying free superoxide radicals in the body. As shown in Fig. 4 , reduced expression and activity of manganese-SOD in the arterioles of STZ-induced diabetic rats were signifi cantly reversed with Xiaokening treatment. XO is an oxidase which that produces reactive oxygen species. Incubation with 5 g/L Xiaokening for 72 hours also signifi cantly decreased XO expression and activity (Fig. 4) , indicating that Xiaokening suppressed diabetes-induced upregulation of XO expression and activity. These results suggest that changes in SOD and XO activity and expression are the mechanisms by which Xiaokening decreases O 2 -activity in STZ-induced diabetic arterioles.
DISCUSSION
In the present study, we found that Xiaokening evoked a concentration-and time-dependent effect on NO release. This effect is related to the reversion of eNOS expression by Xiaokening in the arterioles of STZ-induced diabetic rats, which can be explained by the effect of Xiaokening on XO and SOD expression and activity.
Endothelial dysfunction is considered to be the primary cause of vascular disease in diabetes mellitus. (2, (19) (20) (21) It is characterised by an impaired vascular response to endothelium-derived NO. (22) NO, a major vasoactive substance released by the endothelium, plays an important role in the regulation of a stable internal environment. (23) This regulation involves several physiological and pathological processes, such as the inhibition of neutrophil chemotaxis, the aggregation and adhesion to the vascular endothelium, the inhibition of vascular smooth muscle cell proliferation and migration, the inhibition of the adhesion of monocytes and platelets and the stimulation of endothelial cell growth. The present study found that when shear stress increased gradually from 1 dyn/cm 2 to 20 dyn/cm 2 , NO released from the arteriolar endothelial cells gradually increased in both the control rats and the STZ-induced diabetic rats (Fig. 1) . Reduced NO release in diabetes mellitus damages the dilation function of arterioles. (24, 25) Chinese medicines have been found to have the ability to prevent and treat diabetic nephropathy in the early stages; (26) (27) (28) (29) this may be due to the fact that they are often made of diverse effective components, which are able to act on different targets of diabetic nephropathy. The compound preparation Xiaokening is composed of extractions of rhubarb, radix aconiti lateralis preparata and crude radix astragali. In previous studies, we showed that Xiaokening has positive effects in regulating diabetes mellitus and diabetic nephropathy. (30) (31) (32) In the present study, we found that Xiaokening (1, 3 or 5 g/L for 24, 48 or 72 hours) evoked a concentration-and time-dependent effect on the NO release of arterioles (Fig. 1) . This observed increase in NO release from arteriolar endothelial cells that were treated with Xiaokening suggests that it can improve microvascular function in diabetes mellitus. In the present study, incubation with 5 g/L Xiaokening for 72 hours was the most effective in reversing the effect of shear stress on NO release in the arterioles of STZ-induced diabetic rats. Therefore, incubation with 5 g/L Xiaokening for 72 hours was used to explore the underlying mechanism through which Xiaokening protects arteriolar endothelial function in these rats.
eNOS conjugates tetrahydrobiopterin (BH4) and L-arginine to promote the synthesis of NO in endothelial cells; it is the main source of NO under physiological conditions. (33, 34) Excessive generation of reactive oxygen species is known to impair eNOS activity and NO production, thereby affecting endotheliumdependent vasodilation. (35) In the present study, we found lower eNOS expression in the arterioles of the STZ-induced diabetic rats, but this decrease could be reversed with Xiaokening treatment. This fi nding indicates that Xiaokening enhances NO release from arteriolar endothelial cells via upregulation of eNOS expression.
Chronic hyperglycaemia can cause oxidative stress, which can then result in cellular tissue damage. The structure and function of an organ can be disturbed during uncontrolled hyperglycaemia. (8) Several studies have shown that diabetes mellitus (both type I and type II) is accompanied by an increased formation of free radicals and a decreased antioxidant capacity, resulting in oxidative damage to cell components. (36) STZ has cytotoxic effects against various vital tissues of the pancreas, liver and kidney. STZ-induced diabetes mellitus is associated with the generation of ROS, which causes oxidative damage, (8, 37) and ROS formation plays a major role in diabetes-induced endothelial dysfunction. (38, 39) In the present study, we found that Xiaokening signifi cantly reduced diabetes-induced elevation of O 2 -. This fi nding suggests that Xiaokening may have the ability to protect arterioles against the cytotoxic action of STZ.
Oxidative stress, or an increase in the level of ROS, in the biological system is known to occur due to increased activity of ROS-generating systems and/or decreased antioxidant defence mechanisms. (40) XO is an oxidase that produces reactive oxygen species while SOD, an endogenous scavenger of superoxide, is responsible for destroying free superoxide radicals in the body. In the present study, incubation with 5 g/L Xiaokening for 72 hours reversed XO and SOD expression and activity in the arterioles of STZ-induced diabetic rats. The most effective defence mechanism against diseases such as diabetes mellitus is the removal of O 2 -. The fi ndings of the present study reveal that Xiaokening may be able to balance the oxidative system and thus prevent pathological alterations caused by O 2 -. Imbalance between the oxidant and antioxidant system will increase ROS generation and result in BH4 depletion and eNOS uncoupling. (41) Decreased synthesis and release of NO will then lead to endothelium dysfunction in diabetes mellitus. The results of the present study suggest that Xiaokening is an effective antioxidant that is able to protect arteriolar endothelial function against diabetes-induced endothelial damage. However, this study was practiced in isolated and cultured vessels, and it is still necessary to observe the effect of Xiaokening on diabetic vessels in vivo. Further studies are also needed to expand on and demonstrate the underlying molecular mechanisms of this protective effect.
In conclusion, the results of the present study show that Xiaokening can increase endothelial NO release and improve endothelial function through the inhibition of O 2 -increase in diabetes mellitus. Our fi ndings suggest that Xiaokening has the potential to be developed as a drug for the treatment of diabetesinduced vascular disease. 
